Literature DB >> 21845734

USP7 regulates the stability and function of HLTF through deubiquitination.

Peng Qing1, Lu Han, Liu Bin, Lu Yan, Wen Xue Ping.   

Abstract

Human helicase-like transcription factor (HLTF) is a functional homologue of yeast Rad5 that regulates error-free replication through DNA lesions. HLTF promotes the Lys-63-linked polyubiquitination of proliferating cell nuclear antigen (PCNA) that is required for maintaining genomic stability. Here, we identified the deubiquitylating enzyme ubiquitin-specific protease 7 (USP7) as a novel regulator of HLTF stability. We found that USP7 interacted with and stabilized HLTF after genotoxic stress. Furthermore, USP7 mediated deubiquitination significantly prolonged the half-life of HLTF, which in turn increased PCNA polyubiquitination. More intriguingly, silencing of USP7 rendered A549 cells highly sensitive to DNA damage and over-expression of HLTF attenuated this sensitivity. Thus, our results delineate a previously unknown USP7-HLTF-PCNA molecular network controlling DNA damage response.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21845734     DOI: 10.1002/jcb.23317

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  15 in total

Review 1.  USP7: Structure, substrate specificity, and inhibition.

Authors:  Alexandra Pozhidaeva; Irina Bezsonova
Journal:  DNA Repair (Amst)       Date:  2019-02-16

Review 2.  The helicase-like transcription factor (HLTF) in cancer: loss of function or oncomorphic conversion of a tumor suppressor?

Authors:  Ludovic Dhont; Céline Mascaux; Alexandra Belayew
Journal:  Cell Mol Life Sci       Date:  2016-01       Impact factor: 9.261

Review 3.  Regulation of Mammalian DNA Replication via the Ubiquitin-Proteasome System.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

4.  Structural Characterization of Interaction between Human Ubiquitin-specific Protease 7 and Immediate-Early Protein ICP0 of Herpes Simplex Virus-1.

Authors:  Alexandra K Pozhidaeva; Kareem N Mohni; Sirano Dhe-Paganon; Cheryl H Arrowsmith; Sandra K Weller; Dmitry M Korzhnev; Irina Bezsonova
Journal:  J Biol Chem       Date:  2015-07-29       Impact factor: 5.157

5.  Ubiquitin-specific protease 7 is a regulator of ubiquitin-conjugating enzyme UbE2E1.

Authors:  Feroz Sarkari; Keith Wheaton; Anthony La Delfa; Majda Mohamed; Faryal Shaikh; Rahima Khatun; Cheryl H Arrowsmith; Lori Frappier; Vivian Saridakis; Yi Sheng
Journal:  J Biol Chem       Date:  2013-04-19       Impact factor: 5.157

6.  Environmental contaminants and microRNA regulation: Transcription factors as regulators of toxicant-altered microRNA expression.

Authors:  James Sollome; Elizabeth Martin; Praveen Sethupathy; Rebecca C Fry
Journal:  Toxicol Appl Pharmacol       Date:  2016-06-10       Impact factor: 4.219

7.  USP7 is essential for maintaining Rad18 stability and DNA damage tolerance.

Authors:  A Zlatanou; S Sabbioneda; E S Miller; A Greenwalt; A Aggathanggelou; M M Maurice; A R Lehmann; T Stankovic; C Reverdy; F Colland; C Vaziri; G S Stewart
Journal:  Oncogene       Date:  2015-05-11       Impact factor: 9.867

8.  Role of helicase-like transcription factor (hltf) in the G2/m transition and apoptosis in brain.

Authors:  Rebecca A Helmer; Oded Foreman; Janet S Dertien; Marlyn Panchoo; Suhani M Bhakta; Beverly S Chilton
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

Review 9.  Protein degradation pathways regulate the functions of helicases in the DNA damage response and maintenance of genomic stability.

Authors:  Joshua A Sommers; Avvaru N Suhasini; Robert M Brosh
Journal:  Biomolecules       Date:  2015-04-21

10.  Helicase-like transcription factor (Hltf) regulates G2/M transition, Wt1/Gata4/Hif-1a cardiac transcription networks, and collagen biogenesis.

Authors:  Rebecca A Helmer; Raul Martínez-Zaguilán; Janet S Dertien; Candra Fulford; Oded Foreman; Vasum Peiris; Beverly S Chilton
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.